Divided dose therapies with vascular damaging activity

Details Divided dose therapies with vascular damaging activity Divided dose therapies with vascular damaging activity

A - Human Necessities

61

K

A61K 31/661 (2006.01) A61K 31/66 (2006.01) A61K 33/24 (2006.01) A61K 41/00 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2402078

The invention concerns the use of a vascular damaging agent or a pharmaceutically acceptable salt thereof in the manufacture of a medicament for administration in divided doses for use in the production of a vascular damaging effect in a warm-blooded animal such as a human. In particular the vascular damaging agent is ZD6126, or a pharmaceutically acceptable salt thereof. The invention also relates to methods of treatment using a vascular damaging agent in divided doses.

L'invention concerne l'utilisation d'un agent de dégradation vasculaire ou d'un sel de celui-ci acceptable d'un point de vue pharmaceutique dans la fabrication d'un médicament destiné à être administré en doses fractionnées et destiné à générer un effet de dégradation vasculaire chez un être à sang chaud tel qu'un être humain. L'agent de dégradation vasculaire est notamment ZD6126 ou un sel de celui-ci acceptable d'un point de vue pharmaceutique. L'invention concerne également des procédés de traitement utilisant un agent de dégradation vasculaire en doses fractionnées.

Affiliated with

Also associated with

Rating

Divided dose therapies with vascular damaging activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Divided dose therapies with vascular damaging activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Divided dose therapies with vascular damaging activity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2049284